Xylo Technologies Ltd. (XYLO) - Total Liabilities
Based on the latest financial reports, Xylo Technologies Ltd. (XYLO) has total liabilities worth $19.96 Million USD as of December 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Xylo Technologies Ltd. - Total Liabilities Trend (2016–2024)
This chart illustrates how Xylo Technologies Ltd.'s total liabilities have evolved over time, based on quarterly financial data. See XYLO working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Xylo Technologies Ltd. Competitors by Total Liabilities
The table below lists competitors of Xylo Technologies Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Iqstel Inc
NASDAQ:IQST
|
USA | $30.23 Million |
|
Charan Insurance Public Company Limited
BK:CHARAN
|
Thailand | ฿321.06 Million |
|
Intelligent Bio Solutions Inc.
NASDAQ:INBS
|
USA | $6.61 Million |
|
BIRKS GROUP INC. A
F:2BG
|
Germany | €233.73 Million |
|
The Calmer Co International Ltd
AU:CCO
|
Australia | AU$5.31 Million |
|
Professional Diversity Network Inc
NASDAQ:IPDN
|
USA | $6.69 Million |
|
EXPLOITS DISCOVERY CORP.
F:634
|
Germany | €320.26K |
|
Plascar Participações Industriais S.A
SA:PLAS3
|
Brazil | R$1.31 Billion |
Liability Composition Analysis (2016–2024)
This chart breaks down Xylo Technologies Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see XYLO market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.14 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.11 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.53 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Xylo Technologies Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Xylo Technologies Ltd. (2016–2024)
The table below shows the annual total liabilities of Xylo Technologies Ltd. from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $19.96 Million | -36.56% |
| 2023-12-31 | $31.46 Million | -26.77% |
| 2022-12-31 | $42.96 Million | +417.80% |
| 2021-12-31 | $8.30 Million | +35.11% |
| 2020-12-31 | $6.14 Million | +18.03% |
| 2019-12-31 | $5.20 Million | +64.65% |
| 2018-12-31 | $3.16 Million | +85.99% |
| 2017-12-31 | $1.70 Million | -5.37% |
| 2016-12-31 | $1.80 Million | -- |
About Xylo Technologies Ltd.
Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Great Britain, Israel, Canada, Asia, and internationally. It operates through Corporate, Online Advertising & Internet Traffic Routing, Online Event Management, and Real-estate and Electronics segments. The company offers Medigus Ultrasonic Surgical Endostapler, an endosc… Read more